GlobeNewswire Inc | Jul 7, 2021 04:01PM EDT

July 07, 2021

NEW YORK, July 07, 2021 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic company developing a pipeline of advanced therapeutics based on its proprietary microdose array print (MAP) platform technology, today announced that management will present a corporate overview and host one-one-one meetings at the Ladenburg Thalmann 2021 Healthcare Conference, being held virtually July 13-14, 2021, and host one-on-meetings at the William Blair Biotech Focus Conference 2021, being held virtually July 14-15, 2021.

Details of the Ladenburg presentation are below:

Date: Wednesday, July 14, 2021Time: 9:00AM Eastern TimeWebcast: https://wsw.com/webcast/ladenburg7/eyen/2421499

AboutEyenovia, Inc.

Eyenovia, Inc.(NASDAQ: EYEN) is a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print (MAP) therapeutics.Eyenoviais currently focused on the late-stage development of microdosed medications for presbyopia, myopia progression and mydriasis. For more information, visitwww.eyenovia.com.

The Eyenovia Corporate Information slide deck may be found atir.eyenovia.com/events-and-presentations.

Eyenovia Contact:Eyenovia, Inc.John GandolfoChief Financial Officerjgandolfo@eyenovia.com

Eyenovia Investor Contact:Eric RibnerLifeSci Advisors, LLCeric@lifesciadvisors.com(646) 751-4363

Eyenovia Media Contact:Sam ChoinskiPazanga Health Communicationsschoinski@pazangahealth.com(603) 489-5964